State and Federal Developments

Resources that reflect developments regarding federal and state responses to the opioid epidemic.

Overview of Pharmacists’ Prescriptive Authority of Controlled Substances

Pharmacist Controlled Substance Authority by State

X-Waiver Requirement Removal FAQ (SAMHSA)

Opioid Analgesic REMS 

• REMS Compliant Continuing Education
• Opioid Analgesic REMS Patient Counseling Guide 
• Medication Guides 

National Prescription Drug Take Back Day event (DEA)

National Prescription Drug Take Back Day (DEA)

Reducing Opioid Misuse Letter to Providers (CMS) 

2019 Medicare Part D Opioid Policies: Information for Pharmacies (Tip Sheet) (a webinar is also available) (CMS)   

Opioid Prescribing by Specialty and Volume in the U.S. (CDC) 

Surgeon General's Spotlight on Opioids: Facing Addiction in America

Help, Resources and Information, National Opioid Crisis (HHS) 

• 5-Point Strategy to Combat the Opioid Crisis 

HEAL Initiative Research Plan (NIH)

Surgeon General's Advisory on Naloxone and Opioid Overdose (April 2018)

DEA 360 Strategy

Opioids (Agency for Health Research and Quality) 

White House: The Opioid Crisis

Naloxone Access in Community Pharmacies (National Alliance of State Pharmacy Associations)

The Surgeon General's Report on Alcohol, Drugs, and Health - Facing Addiction in America (November 2016)

National Pain Strategy (HHS)

Preventing the Consequences of Opioid Overdose: Understanding Naloxone Access Laws (SAMHSA)

National and state treatment need and capacity for opioid antagonist medication-assisted treatment

Fact Sheet – FDA Opioids Action Plan

Prescription Drug Time and Dosage Limit Laws (CDC)

The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse (CMS)

State Laws on Prescription Drug Abuse and Misuse (CDC)